Deutsche Bank
OKUR

Deutsche Bank’s OnKure Therapeutics OKUR Stock Holding History

Deutsche Bank’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-472
Closed -$14K – 4358
2022
Q1 		$14K Sell
472
-56
-11% -$3.13K ﹤0.01% 4093
2021
Q4 		$45K Buy
528
+165
+45% +$12.1K ﹤0.01% 3984
2021
Q3 		$27K Sell
363
-12
-3% -$1.02K ﹤0.01% 4207
2021
Q2 		$35K Buy
+375
New +$41.8K ﹤0.01% 4363

Other funds holding OKUR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Deutsche Bank's OKUR Position: Q2 2022 in Review

Deutsche Bank sold out of OnKure Therapeutics (OKUR) in Q2 2022, closing a stake of 472 shares — an estimated $14K sold.

Deutsche Bank first reported a position in OKUR in Q2 2021 and held it in 4 quarters. The position peaked at $45K in Q4 2021. 33 funds tracked by Wall St. Rank hold OKUR as of Q2 2022.

  • Deutsche Bank reported no remaining OnKure Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Deutsche Bank sold 472 OnKure Therapeutics shares in Q2 2022, an estimated $14K.
  • Deutsche Bank first reported a position in OnKure Therapeutics in Q2 2021 and held it in 4 quarters.
  • Deutsche Bank's OnKure Therapeutics position peaked at $45K in Q4 2021.
  • 33 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.